-
1
-
-
0031028402
-
Prognostic factors for thyroid carcinoma: A population-based study of 15 698 cases from the surveillance, epidemiology and end results (SEER) program 1973-1991
-
Gilland FD, Hunt WC, Morris DM, Key CR. Prognostic factors for thyroid carcinoma: a population-based study of 15 698 cases from the surveillance, epidemiology and end results (SEER) program 1973-1991. Cancer 1997;79:564-73.
-
(1997)
Cancer
, vol.79
, pp. 564-573
-
-
Gilland, F.D.1
Hunt, W.C.2
Morris, D.M.3
Key, C.R.4
-
2
-
-
0031752682
-
Anaplastic thyroid carcinoma: Behavior, biology, therapeutic approach
-
Ain KB. Anaplastic thyroid carcinoma: behavior, biology, therapeutic approach. Thyroid 1998;8:715-26.
-
(1998)
Thyroid
, vol.8
, pp. 715-726
-
-
Ain, K.B.1
-
3
-
-
0037249255
-
Anaplastic thyroid cancer
-
Pasieka JL. Anaplastic thyroid cancer. Curr Opin Oncol 2003;15:78-83.
-
(2003)
Curr Opin Oncol
, vol.15
, pp. 78-83
-
-
Pasieka, J.L.1
-
4
-
-
0035039591
-
Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid
-
Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A. Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid. World J Surg 2001;25:617-22.
-
(2001)
World J Surg
, vol.25
, pp. 617-622
-
-
Sugitani, I.1
Kasai, N.2
Fujimoto, Y.3
Yanagisawa, A.4
-
5
-
-
0002049474
-
Histological typing of thyroid tumors
-
Hedinger CE, editor Berlin: Springer-Verlag
-
Hedinger CE. Histological typing of thyroid tumors. In: Hedinger CE, editor. International histological classification of tumors. Vol 11. Berlin: Springer-Verlag; 1988. p. 22-3.
-
(1988)
International Histological Classification of Tumors
, vol.11
, pp. 22-23
-
-
Hedinger, C.E.1
-
6
-
-
0003809049
-
-
American Joint Committee on Cancer 6th ed. Thyroid. New York, NY: Springer Verlag
-
American Joint Committee on Cancer. Cancer Staging Manual. 6th ed. Thyroid. New York, NY: Springer Verlag; 2002. p. 77-87.
-
(2002)
Cancer Staging Manual
, pp. 77-87
-
-
-
7
-
-
0034518391
-
A multimodality therapeutic approach in anaplastic thyroid carcinoma: Study on 39 patients
-
Busnardo B, Daniele O, Pelizzo MR, Mazzarotto R, Nacamulli D, Devido D et al. A multimodality therapeutic approach in anaplastic thyroid carcinoma: study on 39 patients. J Endocrinol Invest 2000;23:755-61.
-
(2000)
J Endocrinol Invest
, vol.23
, pp. 755-761
-
-
Busnardo, B.1
Daniele, O.2
Pelizzo, M.R.3
Mazzarotto, R.4
Nacamulli, D.5
Devido, D.6
-
8
-
-
0036121511
-
The important role of operations in the management of anaplastic thyroid carcinoma
-
Sugino K, Ito K, Mimura T, Nagahama M, Fukunari N, Kubo A et al. The important role of operations in the management of anaplastic thyroid carcinoma. Surgery 2002;131;245-8.
-
(2002)
Surgery
, vol.131
, pp. 245-248
-
-
Sugino, K.1
Ito, K.2
Mimura, T.3
Nagahama, M.4
Fukunari, N.5
Kubo, A.6
-
9
-
-
0035875896
-
Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival
-
Haigh PI, Ituarte PH, Wu HS, Treseler PA, Posner MD, Quivey JM et al. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival. Cancer 2001;91:2335-42.
-
(2001)
Cancer
, vol.91
, pp. 2335-2342
-
-
Haigh, P.I.1
Ituarte, P.H.2
Wu, H.S.3
Treseler, P.A.4
Posner, M.D.5
Quivey, J.M.6
-
10
-
-
0035666788
-
Anaplastic thyroid carcinoma: A 50-year experience at a single institution
-
McIver B, Hay ID, Giuffrida DF, Dvorak CE, Grant CS, Thompson GB et al. Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery 2001;130:1028-34.
-
(2001)
Surgery
, vol.130
, pp. 1028-1034
-
-
McIver, B.1
Hay, I.D.2
Giuffrida, D.F.3
Dvorak, C.E.4
Grant, C.S.5
Thompson, G.B.6
-
11
-
-
15744362272
-
Anaplastic thyroid carcinoma: Treatment outcome and prognostic factors
-
Kebebew E, Greenspan FS, Clark OH, Woeber KA, McMillan A et al. Anaplastic thyroid carcinoma: treatment outcome and prognostic factors. Cancer 2005;103:1330-5.
-
(2005)
Cancer
, vol.103
, pp. 1330-1335
-
-
Kebebew, E.1
Greenspan, F.S.2
Clark, O.H.3
Woeber, K.A.4
McMillan, A.5
-
12
-
-
2942711548
-
Thyroid tissue: US-guided percutaneous laser thermal ablation
-
Pacella CM, Bizzarri G, Spiezia S, Bianchini A, Guglielmi R, Crescenzi A et al. Thyroid tissue: US-guided percutaneous laser thermal ablation. Radiology 2004;232:272-80.
-
(2004)
Radiology
, vol.232
, pp. 272-280
-
-
Pacella, C.M.1
Bizzarri, G.2
Spiezia, S.3
Bianchini, A.4
Guglielmi, R.5
Crescenzi, A.6
-
13
-
-
35348890913
-
Ultrasound-guided percutaneous laser ablation treatment in inoperable aggressive course anaplastic thyroid carcinoma: The introduction of a novel alternative palliative therapy-second experience in literature
-
Cakir B, Topaloglu O, Gul K, Agac T, Aydin C, Dirikoc A et al. Ultrasound-guided percutaneous laser ablation treatment in inoperable aggressive course anaplastic thyroid carcinoma: the introduction of a novel alternative palliative therapy-second experience in literature. J Endocrinol Invest 2007;30:624-5.
-
(2007)
J Endocrinol Invest
, vol.30
, pp. 624-625
-
-
Cakir, B.1
Topaloglu, O.2
Gul, K.3
Agac, T.4
Aydin, C.5
Dirikoc, A.6
-
14
-
-
0036795865
-
Anaplastic thyroid carcinoma: Comparison of conventional radiotherapy and hyperfractionation chemoradiotherapy in two groups
-
Heron DE, Karimpour S, Grigsby PW. Anaplastic thyroid carcinoma: comparison of conventional radiotherapy and hyperfractionation chemoradiotherapy in two groups. Am J Clin Oncol 2002;25:442-6.
-
(2002)
Am J Clin Oncol
, vol.25
, pp. 442-446
-
-
Heron, D.E.1
Karimpour, S.2
Grigsby, P.W.3
-
15
-
-
0037125034
-
Anaplastic thyroid carcinoma: Three protocols combined doxorubicin, hyperfractionated radiotherapy and surgery
-
Tennvall J, Lundell G, Wahlberg P, Bergenfelz A, Grimelius L, Akerman M et al. Anaplastic thyroid carcinoma: three protocols combined doxorubicin, hyperfractionated radiotherapy and surgery. Br J Cancer 2002;86:1848-53.
-
(2002)
Br J Cancer
, vol.86
, pp. 1848-1853
-
-
Tennvall, J.1
Lundell, G.2
Wahlberg, P.3
Bergenfelz, A.4
Grimelius, L.5
Akerman, M.6
-
16
-
-
0034962347
-
Improvement in target coverage and reduced spinal cord irradiation using intensity-modulated radiotherapy (IMRT) in patients with carcinoma of the thyroid gland
-
Nutting CM, Convery DJ, Cosgrove VP, Rowbottom C, Vini L, Harmer C et al. Improvement in target coverage and reduced spinal cord irradiation using intensity-modulated radiotherapy (IMRT) in patients with carcinoma of the thyroid gland. Radiother Oncol 2001;60:173-80.
-
(2001)
Radiother Oncol
, vol.60
, pp. 173-180
-
-
Nutting, C.M.1
Convery, D.J.2
Cosgrove, V.P.3
Rowbottom, C.4
Vini, L.5
Harmer, C.6
-
17
-
-
0026024115
-
Combination therapy for anaplastic giant cell thyroid carcinoma
-
Schlumberger M, Parmentier C, Delisle MJ, Couette JE, Droz JP, Sarrazin D. Combination therapy for anaplastic giant cell thyroid carcinoma. Cancer 1991;67:564-6.
-
(1991)
Cancer
, vol.67
, pp. 564-566
-
-
Schlumberger, M.1
Parmentier, C.2
Delisle, M.J.3
Couette, J.E.4
Droz, J.P.5
Sarrazin, D.6
-
18
-
-
0025916513
-
Combined chemotherapy with bleomycin, adriamycin and platinum in advanced thyroid cancer
-
De Best P, Busnardo B, Toso S, Girelli ME, Nacamulli D, Simioni N et al. Combined chemotherapy with bleomycin, adriamycin and platinum in advanced thyroid cancer. J Endocrinol Invest 1991;14:475-80.
-
(1991)
J Endocrinol Invest
, vol.14
, pp. 475-480
-
-
De Best, P.1
Busnardo, B.2
Toso, S.3
Girelli, M.E.4
Nacamulli, D.5
Simioni, N.6
-
20
-
-
0033840233
-
Treatment of anaplastic thyroid carcinoma with paclitaxel: Phase 2 trial using ninety-six-hour infusion
-
Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group
-
Ain KB, Egorin MJ, DeSimone PA. Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group. Thyroid 2000;10:587-94.
-
(2000)
Thyroid
, vol.10
, pp. 587-594
-
-
Ain, K.B.1
Egorin, M.J.2
Desimone, P.A.3
-
21
-
-
0033768918
-
Cytotoxic activity of 2′, 2′ difluorodeoxycytidine (Gemcitabine) in poorly differentiated thyroid carcinoma cells
-
Ringel MD, Greenberg M, Chen X, Hayre N, Suzuki K, Priebat D et al. Cytotoxic activity of 2′, 2′ difluorodeoxycytidine (Gemcitabine) in poorly differentiated thyroid carcinoma cells. Thyroid 2000;10:865-9.
-
(2000)
Thyroid
, vol.10
, pp. 865-869
-
-
Ringel, M.D.1
Greenberg, M.2
Chen, X.3
Hayre, N.4
Suzuki, K.5
Priebat, D.6
-
22
-
-
0034523426
-
Adenovirus mediated tumor suppressor p 53 gene therapy for anaplastic thyroid carcinoma in vitro and in vivo
-
Nagayama Y, Yokoi H, Takeda K, Hasegawa M, Nishihara E, Namba H et al. Adenovirus mediated tumor suppressor p 53 gene therapy for anaplastic thyroid carcinoma in vitro and in vivo. J Clin Endocrinol Metab 2000;85:4081-6.
-
(2000)
J Clin Endocrinol Metab
, vol.85
, pp. 4081-4086
-
-
Nagayama, Y.1
Yokoi, H.2
Takeda, K.3
Hasegawa, M.4
Nishihara, E.5
Namba, H.6
-
23
-
-
0037986203
-
The selective tyrosine kinase inhibitor, ST 1571, inhibits growth of anaplastic thyroid cancer cells
-
Podtcheko A, Ohtsuru A, Tsuda S, Namba H, Saenko V, Nakashima M et al. The selective tyrosine kinase inhibitor, ST 1571, inhibits growth of anaplastic thyroid cancer cells. J Clin Endocrinol Metab 2003;88:1889-96.
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 1889-1896
-
-
Podtcheko, A.1
Ohtsuru, A.2
Tsuda, S.3
Namba, H.4
Saenko, V.5
Nakashima, M.6
-
24
-
-
2542458413
-
Histone deacetylase inhibitors restore radioiodide uptake and retention in poorly differentiated and anaplastic thyroid cancer cells by espression of the sodium/iodide symporter, thyroperoxidase and thyroglobulin
-
Furuya F, Shimura H, Suzuki H, Taki K, Ohta K, Haraguchi K et al. Histone deacetylase inhibitors restore radioiodide uptake and retention in poorly differentiated and anaplastic thyroid cancer cells by espression of the sodium/iodide symporter, thyroperoxidase and thyroglobulin. Endocrinol 2004;145:2865-75.
-
(2004)
Endocrinol
, vol.145
, pp. 2865-2875
-
-
Furuya, F.1
Shimura, H.2
Suzuki, H.3
Taki, K.4
Ohta, K.5
Haraguchi, K.6
-
25
-
-
33751505528
-
Valproic acid, a histone deacetylase inhibitor, enhances sensitivity to doxorubicin in anaplastic thyroid cancer cells
-
Catalano MG, Fortunati N, Pugliese M, Poli R, Bosco O, Mastrocola R et al. Valproic acid, a histone deacetylase inhibitor, enhances sensitivity to doxorubicin in anaplastic thyroid cancer cells. J Endocrinol 2006;191:465-72.
-
(2006)
J Endocrinol
, vol.191
, pp. 465-472
-
-
Catalano, M.G.1
Fortunati, N.2
Pugliese, M.3
Poli, R.4
Bosco, O.5
Mastrocola, R.6
-
26
-
-
1442352159
-
Valproic acid induces expression of the Na+/I- Symporter and iodine uptake in poorly differentiated thyroid cancer cells
-
Fortunati N, Catalano MG, Arena K, Brignardello E, Piovesan A, Boccuzzi G. Valproic acid induces expression of the Na+/I- symporter and iodine uptake in poorly differentiated thyroid cancer cells. J Clin Endocrinol and Metabolism 2004;89:1006-9.
-
(2004)
J Clin Endocrinol and Metabolism
, vol.89
, pp. 1006-1009
-
-
Fortunati, N.1
Catalano, M.G.2
Arena, K.3
Brignardello, E.4
Piovesan, A.5
Boccuzzi, G.6
-
27
-
-
0003594866
-
Guidelines for the management of thyroid cancer
-
British Thyroid Association, Royal College of Physicians Perros P, editor. 2nd ed. London: Royal College Physicians
-
British Thyroid Association, Royal College of Physicians. Guidelines for the management of thyroid cancer. In: Perros P, editor. 2nd ed. Report the Thyroid Cancer Guidelines Update Group. London: Royal College Physicians; 2007.
-
(2007)
Report the Thyroid Cancer Guidelines Update Group
-
-
-
28
-
-
47549092154
-
18F-FDG PET in the management of patients with anaplastic thyroid carcinoma
-
Bosgrud TV, Karantanis D, Nathan MA, Mullan BP, Wiseman GA, Kasperbauer JL et al. 18F-FDG PET in the management of patients with anaplastic thyroid carcinoma. Thyroid 2008;18:713-9.
-
(2008)
Thyroid
, vol.18
, pp. 713-719
-
-
Bosgrud, T.V.1
Karantanis, D.2
Nathan, M.A.3
Mullan, B.P.4
Wiseman, G.A.5
Kasperbauer, J.L.6
-
29
-
-
60849091644
-
Anaplastic thyroid cancer: Prevalence, diagnosis and treatment
-
Chiacchio S, Lorenzoni A, Boni G, Rubello D, Elisei R, Mariani G. Anaplastic thyroid cancer: prevalence, diagnosis and treatment. Minerva Endocrinol 2008;33:341-57.
-
(2008)
Minerva Endocrinol
, vol.33
, pp. 341-357
-
-
Chiacchio, S.1
Lorenzoni, A.2
Boni, G.3
Rubello, D.4
Elisei, R.5
Mariani, G.6
|